# EDGAR Filing Document

**Accession Number:** 0001837796
**File Stem:** 0001773751-25-000357
**Filing Date:** 2025-11
**Character Count:** 10614
**Document Hash:** 5af8a06e6daf736fa4ba7cf29e4c0de0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001773751-25-000357.hdr.sgml**: 20251112

**ACCESSION NUMBER**: 0001773751-25-000357

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251107

**FILED AS OF DATE**: 20251112

**DATE AS OF CHANGE**: 20251112

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Dudum Andrew
- **CENTRAL INDEX KEY:** 0001837796

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38986
- **FILM NUMBER:** 251474977

**MAIL ADDRESS:**
- **STREET 1:** 2269 CHESTNUT STREET, #523
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94123
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Hims & Hers Health, Inc.
- **CENTRAL INDEX KEY:** 0001773751
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 2269 CHESTNUT ST
- **STREET 2:** #523
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94123
- **BUSINESS PHONE:** 415-851-0195

**MAIL ADDRESS:**
- **STREET 1:** 2269 CHESTNUT ST
- **STREET 2:** #523
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94123

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Oaktree Acquisition Corp.
- **DATE OF NAME CHANGE:** 20190412

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Dudum Andrew<br><sub>(Last) (First) (Middle)</sub><br>2269 CHESTNUT STREET, #523<br><sub>(Street)</sub><br>SAN FRANCISCO, CA 94123<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-11-07 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [X] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Executive Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Hims & Hers Health, Inc. [ HIMS ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Class A Common Stock |  |  |  |  |  |  |  | 791117<sup>(1)</sup> | I | Held by Trustee of AD 2022 GRAT 2 dated 9/7/2022 |
| Class A Common Stock |  |  |  |  |  |  |  | 262423<sup>(2)</sup> | I | Held by Trustee of AD 2021 GRAT 2 dated 11-1-2021 |
| Class A Common Stock | 2025-11-07 |  | G |  | 262423<sup>(3)</sup> | D | $0 | 0 | I | Held by Trustee of AD 2021 GRAT 2 dated 11-1-2021 |
| Class A Common Stock | 2025-11-07 |  | G |  | 262423<sup>(3)</sup> | A | $0 | 262423 | I | Held by Trustee of Dudum Legacy 2021 Trust |
| Class A Common Stock | 2025-11-10 |  | J |  | 260000<sup>(4)</sup> | D | $0 | 2423 | I | Held by Trustee of Dudum Legacy 2021 Trust |
| Class A Common Stock |  |  |  |  |  |  |  | 1049692<sup>(5)</sup> | I | Held by Trustee of AD 2021 GRAT dated 11-1-2021 |
| Class A Common Stock | 2025-11-10 |  | G |  | 1049692<sup>(6)</sup> | D | $0 | 0 | I | Held by Trustee of AD 2021 GRAT dated 11-1-2021 |
| Class A Common Stock | 2025-11-10 |  | G |  | 1049692<sup>(6)</sup> | A | $0 | 1049692 | I | Held by Trustee of Dudum Family 2021 Trust |
| Class A Common Stock |  |  |  |  |  |  |  | 508030 | I | Held by Trustee of AD 2022 GRAT |
| Class A Common Stock |  |  |  |  |  |  |  | 1194545 | I | Held by Trustee of AD 2022 GRAT 3 dated 11-28-2022 |
| Class A Common Stock |  |  |  |  |  |  |  | 186723 | I | Held by Trustee of AD 2025 GRAT dated 5-27-2025 |
| Class A Common Stock |  |  |  |  |  |  |  | 47524 | I | Held by Trustee of Dudum Family Community Property Trust |
| Class A Common Stock |  |  |  |  |  |  |  | 2214769 | I | Held by Trustee of Dudum Family Heritage Trust UAD 8-10-2021 |
| Class A Common Stock |  |  |  |  |  |  |  | 981235<sup>(7)</sup> | I | Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015 |
| Class A Common Stock |  |  |  |  |  |  |  | 1954379<sup>(8)</sup> | I | Held by Trustee of AD 2023 GRAT dated 9-5-2023 |
| Class A Common Stock |  |  |  |  |  |  |  | 92523 | D |  |
| Class A Common Stock | 2025-11-12 |  | G |  | 1954379<sup>(9)</sup> | D | $0 | 0 | I | Held by Trustee of AD 2023 GRAT dated 9-5-2023 |
| Class A Common Stock | 2025-11-12 |  | G |  | 1954379<sup>(9)</sup> | A | $0 | 3004071 | I | Held by Trustee of Dudum Family 2021 Trust |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Class V Common Stock | <sup>(10)</sup> |  |  |  |  |  |  | <sup>(10)</sup> | <sup>(10)</sup> | Class A Common Stock | 8377623<sup>(11)</sup> |  | 8377623 | I | Held by Andrew Dudum 2015 Trust Dated July 2, 2015 |
| Class V Common Stock | <sup>(10)</sup> |  |  |  |  |  |  | <sup>(10)</sup> | <sup>(10)</sup> | Class A Common Stock | 0<sup>(11)</sup> |  | 0 | I | Held by Trustee of the AD 2023 GRAT dated 9-5-2023 |

---

### Footnotes:

(1) This amount reflects an annuity payment-in-kind of 38,068 shares of Class A Common Stock from the AD 2022 GRAT 2 dated 9-7-2022 to the Andrew Dudum 2015 Trust dated July 2, 2015 .

(2) This amount reflects an annuity payment-in-kind of 59,234 shares of Class A Common Stock from the AD 2021 GRAT 2 dated 11-1-2021 to the Andrew Dudum 2015 Trust dated July 2, 2015 .

(3) These shares represent a gift to the Dudum Legacy 2021 Trust from the AD 2021 GRAT 2 dated 11-1-2021.

(4) This transaction represents a pro rata distribution, for no consideration, by the trust to its beneficiaries, of an aggregate of 260,000 shares of Class A Common Stock for bona fide estate planning purposes.

(5) This amount reflects an annuity payment-in-kind of 236,935 shares of Class A Common Stock from the AD 2021 GRAT dated 11-1-2021 to the Andrew Dudum 2015 Trust dated July 2, 2015.

(6) These shares represent a gift to the Dudum Family 2021 Trust from the AD 2021 GRAT dated 11-1-2021.

(7) This amount reflects annuity payments-in-kind to the Andrew Dudum 2015 Trust dated July 2, 2015 in the following amounts of Class A Common Stock: 1) 236,935 shares from the AD 2021 GRATdated 11-1-2021; 2) 59,234 shares from the AD 2021 GRAT 2 dated 11-1-2021; 3) 38,068 shares from the AD 2022 GRAT 2 dated 9-7-2022; and 4) 216,266 shares from the AD GRAT 2023 dated 9-5-2023.  The balance also includes a transfer of 586,139 Class A Shares to the AD GRAT 2023 dated 9-5-2023.

(8) This amount reflects 1) an annuity payment-in-kind of 216,266 shares of Class A Common Stock from the AD 2023 GRAT dated 9-5-2023 to the Andrew Dudum 2015 Trust dated July 2, 2015 and 2) a transfer of 586,139 Class A Common Stock to the AD GRAT 2023 dated 9-5-2023 from the Andrew Dudum 2015 Trust dated July 2, 2015.

(9) These shares represent a gift to the Dudum Family 2021 Trust from the AD 2023 GRAT dated 9-5-2023.

(10) Class V Common Stock is convertible into an equal number of fully paid and nonassessable shares of Class A Common Stock upon certain events.

(11) This amount reflects a transfer of 586,139 shares of Class V Common Stock from the AD 2023 GRAT dated 9-1-2023 to the Andrew Dudum 2015 Trust dated July 2, 2015. The reporting person is deemed to have sole voting and disposition power over the securities held by the AD 2023 GRAT dated 9-1-2023 and the Andrew Dudum 2015 Trust dated July 2, 2015.

**Signature:** /s/ Kimberly Mather, Attorney-in-Fact for Andrew Dudum  
**Date:** 2025-11-12

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**